Oligomer

ProMIS Neurosciences to Showcase PMN310 at International Conference on Cognitive & Behavioral Neurosciences

ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company specializing in antibody therapeutics for neurodegenerative diseases like Alzheimer's disease (AD), amyotrophic...